Drug intelligence / Profile preview

desoximetasone + tacrolimus

Development stage
Preclinical
Lead developer
Taro
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Desoximetasone + tacrolimus is a topical combination of two active pharmaceutical ingredients used primarily in dermatology. Desoximetasone is a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties, acting mainly by binding to the glucocorticoid receptor to modulate gene expression and suppress inflammatory mediators. Tacrolimus is a macrolide immunosuppressant that inhibits calcineurin by binding to FKBP-12, thereby blocking T-lymphocyte activation and cytokine (notably IL-2) transcription. This combination may be used off-label for inflammatory skin conditions such as atopic dermatitis when monotherapy is insufficient or for short-term management of severe disease. Studies have shown that these agents are physically and chemically compatible when mixed in equal parts as ointments[1][4]. Each drug retains its mechanism of action within the mixture.

Brand names
Topicort + Protopic
Other names
desoximetasone and tacrolimusdesoxymethasone + fujimycinTopicort and Protopic
02

Targets

GR (Glucocorticoid receptor)PPP3CA (Protein phosphatase 3 catalytic subunit alpha)

Beyond the preview

Go deeper on desoximetasone + tacrolimus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desoximetasone + tacrolimus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call